Steven King - Insider Trading & Ownership

Entity
Individual
Summary
The estimated net worth of Steven King is at least $86.6K dollars as of February 22, 2022. Steven King is the Director of Oncotelic Therapeutics, Inc. and owns shares of Oncotelic Therapeutics, Inc. (OTLC) stock worth about $86.6K.
All Insider Reports
All Insider Reports

Ownership of Steven King

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
OTLC Oncotelic Therapeutics, Inc. Director $86.6K Sep 3, 2021
CPMV Mosaic ImmunoEngineering Inc. President and CEO, Director, 10%+ Owner Feb 18, 2022

Insider Transactions Reported by Steven King:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.